[PDF][PDF] Landscape analysis of phase 2 and 3 clinical trials for targeted radionuclide therapy

E Mittra, L Bodei - Journal of Nuclear Medicine, 2021 - Soc Nuclear Med
Within nuclear medicine, theranostics has revitalized the field of targeted radionuclide
therapy, and there are a growing number of investigator-initiated and industry-sponsored …

[HTML][HTML] A brief overview of targeted radionuclide therapy trials in 2022

A Healy, E Ho, P Kuo, K Zukotynski - Frontiers in Nuclear Medicine, 2023 - frontiersin.org
There continued future growth of radionuclide therapy for the treatment of oncology patients,
depends on the current wave of clinical trials utilizing radioactive pharmaceuticals to target …

[PDF][PDF] The Australasian Radiopharmaceutical Trials Network: clinical trials, evidence, and opportunity

RJ Francis, DL Bailey, MS Hofman… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Recent advances in technology and discovery have led to a key role for nuclear medicine in
precision health and individualized patient care. As we enter this era of promise and growth …

Targeted radionuclide therapy: proceedings of a joint workshop hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging

F Fahey, K Zukotynski, J Capala, N Knight… - Journal of Nuclear …, 2014 - Soc Nuclear Med
The growing interest in targeted radionuclide therapy (TRT) for a broad range of applications
is shared by a diverse group of medical professionals, including but not limited to physicians …

Proceedings of the Second NCI–SNMMI workshop on targeted radionuclide therapy

F Fahey, K Zukotynski, H Jadvar… - Journal of Nuclear …, 2015 - Soc Nuclear Med
In 2013, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the National
Cancer Institute (NCI) partnered for the first time to host a joint workshop on targeted …

Climbing the steps of the evidence-based medicine pyramid: highlights from Annals of Nuclear Medicine 2019

F Gelardi, M Kirienko, M Sollini - European Journal of Nuclear Medicine …, 2021 - Springer
We aimed to provide an overview on research path in nuclear medicine climbing the steps of
the Evidence-Based Medicine (EBM) pyramid using review of 14 subjectively selected …

[HTML][HTML] The new Regulation on clinical trials in relation to radiopharmaceuticals: when and how will it be implemented?

I Peńuelas, DJ Vugts, C Decristoforo… - EJNMMI radiopharmacy …, 2019 - Springer
The development of radiopharmaceuticals with high specificity and high potential is
increasing dramatically. This opens new doors in clinical research and changes clinical …

A pragmatic perspective on molecular targeted radionuclide therapy

SM Larson, EP Krenning - Journal of Nuclear Medicine, 2005 - Soc Nuclear Med
This collection of reviews and papers on targeted radionuclide therapy provides a snapshot
of the current status of modern clinical applications of therapeutic nuclear medicine. The …

[HTML][HTML] Present and future of target therapies and theranostics: refining traditions and exploring new frontiers—highlights from annals of Nuclear Medicine 2021

C Pini, F Gelardi, M Sollini - European Journal of Nuclear Medicine and …, 2022 - Springer
The first clinical application of nuclear medicine treatments can be dated back to 1936, when
John H. Lawrence utilised an artificial radionuclide—phosphorus-32—to treat a case of …

Radiation oncology and radiopharmaceuticals: Making our own history while learning from the past

JM Buatti, RD Ennis, AP Kiess… - International journal of …, 2023 - redjournal.org
The American Society for Radiation Oncology (ASTRO) and the Radiopharmaceutical Task
Group appreciated the sage comments made in “Radiation Oncologists and Therapeutic …